BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18228134)

  • 1. Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?
    Russo A; Calò V; Bruno L; Schirò V; Agnese V; Cascio S; Foddai E; Fanale D; Rizzo S; Di Gaudio F; Gulotta E; Surmacz E; Di Fede G; Bazan V
    Breast Cancer Res Treat; 2009 Jan; 113(1):67-70. PubMed ID: 18228134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer.
    Baudi F; Quaresima B; Grandinetti C; Cuda G; Faniello C; Tassone P; Barbieri V; Bisegna R; Ricevuto E; Conforti S; Viel A; Marchetti P; Ficorella C; Radice P; Costanzo F; Venuta S
    Hum Mutat; 2001 Aug; 18(2):163-4. PubMed ID: 11462242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 genetic testing in 106 breast and ovarian cancer families from Southern Italy (Sicily): a mutation analyses.
    Russo A; Calò V; Agnese V; Bruno L; Corsale S; Augello C; Gargano G; Barbera F; Cascio S; Intrivici C; Rinaldi G; Gulotta G; Macaluso M; Surmacz E; Giordano A; Gebbia N; Bazan V
    Breast Cancer Res Treat; 2007 Nov; 105(3):267-76. PubMed ID: 17221156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation.
    Bergman A; Einbeigi Z; Olofsson U; Taib Z; Wallgren A; Karlsson P; Wahlström J; Martinsson T; Nordling M
    Eur J Hum Genet; 2001 Oct; 9(10):787-93. PubMed ID: 11781691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [BRCA1 1100delAT is a recurrent mutation in Chinese women with familial breast cancer].
    Li WF; Hu Z; Zhang B; Cao MZ; Wang YS; Liu XY; Zhao L; Liu YB; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):76-80. PubMed ID: 17418009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history.
    Anagnostopoulos T; Pertesi M; Konstantopoulou I; Armaou S; Kamakari S; Nasioulas G; Athanasiou A; Dobrovic A; Young MA; Goldgar D; Fountzilas G; Yannoukakos D
    Breast Cancer Res Treat; 2008 Jul; 110(2):377-85. PubMed ID: 17902052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo.
    Quaresima B; Romeo F; Faniello MC; Di Sanzo M; Liu CG; Lavecchia A; Taccioli C; Gaudio E; Baudi F; Trapasso F; Croce CM; Cuda G; Costanzo F
    Clin Cancer Res; 2008 Nov; 14(21):6797-803. PubMed ID: 18980973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily).
    Russo A; Calò V; Augello C; Bruno L; Agnese V; Schirò V; Barbera F; Cascio S; Foddai E; Badalamenti G; Intrivici C; Cajozzo M; Gulotta G; Surmacz E; Colucci G; Gebbia N; Bazan V
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi99-102. PubMed ID: 17591844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.
    Petrij-Bosch A; Peelen T; van Vliet M; van Eijk R; Olmer R; Drüsedau M; Hogervorst FB; Hageman S; Arts PJ; Ligtenberg MJ; Meijers-Heijboer H; Klijn JG; Vasen HF; Cornelisse CJ; van 't Veer LJ; Bakker E; van Ommen GJ; Devilee P
    Nat Genet; 1997 Nov; 17(3):341-5. PubMed ID: 9354803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
    Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
    Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript.
    Vega A; Campos B; Bressac-De-Paillerets B; Bond PM; Janin N; Douglas FS; Domènech M; Baena M; Pericay C; Alonso C; Carracedo A; Baiget M; Diez O
    Hum Mutat; 2001 Jun; 17(6):520-1. PubMed ID: 11385711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population.
    Pertesi M; Konstantopoulou I; Yannoukakos D
    Clin Genet; 2011 Oct; 80(4):375-82. PubMed ID: 20840220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstructing the genealogy of a BRCA1 founder mutation by phylogenetic analysis.
    Marroni F; Cipollini G; Peissel B; D'Andrea E; Pensabene M; Radice P; Caligo MA; Presciuttini S; Bevilacqua G
    Ann Hum Genet; 2008 May; 72(Pt 3):310-8. PubMed ID: 18215206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer.
    Thomassen M; Hansen TV; Borg A; Lianee HT; Wikman F; Pedersen IS; Bisgaard ML; Nielsen FC; Kruse TA; Gerdes AM
    Acta Oncol; 2008; 47(4):772-7. PubMed ID: 18465347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel BRCA1 mutation in an Indian family with hereditary breast/ovarian cancer.
    Gajalakshmi P; Natarajan TG; Selvi Rani D; Thangaraj K
    Breast Cancer Res Treat; 2007 Jan; 101(1):3-6. PubMed ID: 17131039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populations.
    Rudkin TM; Hamel N; Galvez M; Hogervorst F; Gille JJ; Møller P; Apold J; Foulkes WD
    BMC Med Genet; 2006 Mar; 7():15. PubMed ID: 16509964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 mutations and prostate cancer in Poland.
    Cybulski C; Górski B; Gronwald J; Huzarski T; Byrski T; Debniak T; Jakubowska A; Wokołorczyk D; Gliniewicz B; Sikorski A; Stawicka M; Godlewski D; Kwias Z; Antczak A; Krajka K; Lauer W; Sosnowski M; Sikorska-Radek P; Bar K; Klijer R; Romuald Z; Małkiewicz B; Borkowski A; Borkowski T; Szwiec M; Posmyk M; Narod SA; Lubiński J
    Eur J Cancer Prev; 2008 Feb; 17(1):62-6. PubMed ID: 18090912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Founder mutation in the BRCA1 gene in Malay breast cancer patients from Singapore.
    Lee AS; Ho GH; Oh PC; Balram C; Ooi LL; Lim DT; Wong CY; Hong GS
    Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer.
    Calò V; Agnese V; Gargano G; Corsale S; Gregorio V; Cascio S; Cammareri P; Bruno L; Augello C; Gullo A; Sisto PS; Badalamenti G; Valerio MR; Napoli L; Gebbia N; Bazan V; Russo A
    Breast Cancer Res Treat; 2006 Mar; 96(1):97-100. PubMed ID: 16244786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent origin of 185delAG BRCA1 mutation in an Indian family.
    Kadalmani K; Deepa S; Bagavathi S; Anishetty S; Thangaraj K; Gajalakshmi P
    Neoplasma; 2007; 54(1):51-6. PubMed ID: 17203892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.